Results 191 to 200 of about 36,146 (282)

A thematic analysis of patients' experiences of receiving treatment for Neovascular age-related macular degeneration (nAMD). [PDF]

Eye (Lond)
Hapeshi J, Hughes S, McKibbin M, Scanlon PH.   +3 more
europepmc   +1 more source

Early Detection Of neovascular age-Related mAcular Degeneration in the cOmmunity assessing persistence, adherence and acceptability: study protocol for the DORADO randomized controlled trial. [PDF]

Trials
Hanson RLW, Airody A, Saad A, Gale RP.
europepmc   +1 more source

RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

, 2019
Frank G. Holz, Marta S. Figueroa, Francesco Bandello, Yit C. Yang, Masahito Ohji, Hong Dai, Halina Wykrota, Sanjay Sharma, Cornelia Dunger‐Baldauf, Sue Lacey, Wayne Macfadden, Paul Mitchell, on behalf of all the LUMINOUS study investigators   +12 more
openalex   +1 more source

Impaired Vagal Tone Function-Based Regulation of Systemic Inflammation in Patients With Neovascular Age-Related Macular Degeneration. [PDF]

Invest Ophthalmol Vis Sci
Molbech CR, Bøegh MM, Nielsen MK, Subhi Y, Liisborg C, Roubeix C, Sennlaub F, Mehlsen J, Sørensen TL.   +8 more
europepmc   +1 more source

Development of focal choroidal excavation in non-neovascular age related macular degeneration with pachy-choroid features

, 2019
Touka Banaee, Lance J. Lyons, Jaafar El-Annan   +2 more
openalex   +1 more source

Consensus of Expert Recommendations for the Safe Administration of Brolucizumab in Neovascular Age-related Macular Degeneration. [PDF]

Korean J Ophthalmol
Song JR, Park KH, Kang SW, Chin HS, Yu SY, Park YH, Kim YC, Lee JE, Lim ST, Kim JG, Kim CR, Sagong M, Oh HS, Lee CS, Woo SJ.   +14 more
europepmc   +1 more source

Comment on: The role of posterior vitreous detachment on the efficacy of anti–vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration

, 2019
Upma Awasthi, Rohini Grover, Chetan Videkar, Abhishek Varshney   +3 more
openalex   +1 more source

Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration. [PDF]

Br J Ophthalmol
Borrelli E, Foti C, Ulla L, Porreca A, Introini U, Grassi MO, Viggiano P, Peronetti M, Toscani R, Boscia G, Termite AC, Gennaro C, Marolo P, Boscia F, Bandello F, Reibaldi M.   +15 more
europepmc   +1 more source

One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. [PDF]

Ophthalmol Ther
Tillmann A, Stillenmunkes R, Garweg JG, Cattaneo J, Bartolomeo N, Grimaldi G, Spitznagel T, De Oliveira Figueiredo EC, Ambresin A, Menghini M, Somfai GM, Zweifel S, Fröhlich J, Artemiev D, Ebneter A, Hatz K, Weinberger A, Pfister IB, Schild C, Eandi C, Munk MR, Swiss Retina Research Network.   +21 more
europepmc   +1 more source